Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 788
MIM: 613698
HGNC: 1421
Ensembl: ENSG00000178537
Variants:
dbSNP: 788
ClinVar: 788
TCGA: ENSG00000178537
COSMIC: SLC25A20
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000178537 | ENST00000319017 | O43772 |
| ENSG00000178537 | ENST00000430379 | C9JPE1 |
| ENSG00000178537 | ENST00000440964 | F8WEF6 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38565514 | 2024 | [Clinical and genetic analysis of two pedigrees affected with Carnitine-acylcarnitine translocase deficiency due to variant of SLC25A20 gene]. | 0 |
| 38565514 | 2024 | [Clinical and genetic analysis of two pedigrees affected with Carnitine-acylcarnitine translocase deficiency due to variant of SLC25A20 gene]. | 0 |
| 37371573 | 2023 | Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications. | 0 |
| 37371573 | 2023 | Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications. | 0 |
| 34449152 | 2021 | Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant. | 2 |
| 34626609 | 2021 | Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia. | 5 |
| 34449152 | 2021 | Clinical and molecular characteristics of carnitineacylcarnitine translocase deficiency with c.270delC and a novel c.408C>A variant. | 2 |
| 34626609 | 2021 | Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia. | 5 |
| 28671672 | 2017 | Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences. | 34 |
| 29137068 | 2017 | Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review. | 10 |
| 28671672 | 2017 | Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences. | 34 |
| 29137068 | 2017 | Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review. | 10 |
| 25325845 | 2014 | Identification of amino acid residues underlying the antiport mechanism of the mitochondrial carnitine/acylcarnitine carrier by site-directed mutagenesis and chemical labeling. | 6 |
| 25325845 | 2014 | Identification of amino acid residues underlying the antiport mechanism of the mitochondrial carnitine/acylcarnitine carrier by site-directed mutagenesis and chemical labeling. | 6 |
| 23266187 | 2013 | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 0 |
Citation
Dessen P
SLC25A20 (solute carrier family 25 member 20)
Atlas Genet Cytogenet Oncol Haematol. 2017-11-01
Online version: http://atlasgeneticsoncology.org/gene/57257/slc25a20-(solute-carrier-family-25-member-20)
